Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe — Jae Il Shin (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe
JS
Shared by
Jae Il Shin
Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe
Article
2011
en
Authors
JS
Jae Il Shin
SP
Se Jin Park
JK
Ji Hong Kim
Related publications
Letter
2011
Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis?
Jae Il Shin
,
Se Jin Park
,
Ji Hong Kim
Letter
2010
Could decreased vasopressin secretion be the cause of enuresis in children with migraine?
Se Jin Park
,
Ji Hong Kim
,
Jae Il Shin
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Letter
2011
Could intradialytic hypotension be due to low baseline magnesium levels or inflammation in hemodialysis patients?
Jae Il Shin
,
Se Jin Park
,
Ji Hong Kim
Letter
2012
What should be the indications for fibrinolytic therapy in children with severe Henoch–Schönlein purpura nephritis?
Se Jin Park
,
Jae Il Shin
Letter
2008
Intravenous Cyclophosphamide Therapy in Adults with Henoch-Schönlein Purpura
Jae Il Shin
,
Jae Seung Lee
Discussion(0)
No comments yet. Be the first to comment.